Clonidine, a centrally active alpha-adrenergic agonist, suppresses the release of catecholamines from the adrenal cortex in normal persons. However, it does not inhibit the release from patients with pheochromocytoma. The test is used in the differential diagnosis of hypertension when pheochromocytoma is suspected or needs to be excluded.
